Pobric, Gorana
Taylor, Jason R.
Ramalingam, Hemavathy M.
Pye, Emily
Robinson, Louise
Vassallo, Grace
Jung, JeYoung
Bhandary, Misty
Szumanska-Ryt, Karolina
Theodosiou, Louise
Evans, D. Gareth
Eelloo, Judith
Burkitt-Wright, Emma
Hulleman, Johan
Green, Jonathan
Garg, Shruti http://orcid.org/0000-0002-4472-4583
Funding for this research was provided by:
Newlife – The Charity for Disabled Children (SG/15-16/06)
Neurofibromatosis Therapeutic Acceleration Program
Manchester Biomedical Research Centre (IS-BRC-1215-20007)
NIHR Senior Investigator Award
Beacon Anne McLaren Research Fellowship
Article History
Accepted: 21 April 2021
First Online: 8 May 2021
Declarations
:
: Ethical approval was obtained from Greater Manchester West Research Ethics Committee (17/NW/0364). Data for this study was collected as part of a larger clinical trial in participants with NF1 (registered under clinical trials NCT03310996)